Lehigh County has installed two round-the-clock public health kiosks that dispense free naloxone and other harm-reduction ...
Merck (NYSE:MRK) is restructuring its pharmaceutical business into two divisions, Oncology and Specialty/Pharma & Infectious ...
Department of Correction Commissioner Angel Quiros, who was appointed as COVID was upending the correction system in 2020, ...
SAN FRANCISCO -- Dual antiangiogenic therapy for previously treated kidney cancer significantly improved progression-free survival (PFS) versus a single drug, a large randomized trial showed.
BioMarin Pharmaceutical Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the company's supplemental Biologics License Application (sBLA) for PALYNZIQ® ...
Treatment with PALYNZIQ led to statistically significant blood phenylalanine (Phe) lowering compared to diet alone in pivotal Phase 3 PEGASUS study PALYNZIQ is the ...
Acadia Pharmaceuticals' two approved drugs, NUPLAZID and DAYBUE are guided to continue their strong growth trajectories. Read ...
Findings presented at the 2026 ASCO GU Symposium show that combinatorial therapies may provide new treatment options for patients with renal cell carcinoma or muscle-invasive bladder cancer.
Dana-Farber Cancer Institute presents phase 3 LITESPARK-022 data at the 2026 ASCO Genitourinary Cancers SymposiumPatients ...
On a summer night in 2019 near where the Salish Sea hugs the lands of the Lummi Nation reservation, 17-year-old Merandalee ...
BioNTech and partner DualityBio are accelerating the development of their B7-H3 antibody-drug conjugate into a phase 3 trial for metastatic castration-resistant prostate cancer (mCRPC). | BioNTech and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results